Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Open Access
- 1 November 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 98 (9) , 2094-2099
- https://doi.org/10.1172/jci119015
Abstract
Patients with coronary artery disease or heart failure have been shown to be insulin resistant. Whether in these patients heart muscle participates in the insulin resistance, and whether reduced blood flow is a mechanism for such resistance is not known. We measured heart and skeletal muscle blood flow and glucose uptake during euglycemic hyperinsulinemia (insulin clamp) in 15 male patients with angiographically proven coronary artery disease and chronic regional wall motion abnormalities. Six age- and weight-matched healthy subjects served as controls. Regional glucose uptake was measured by positron emission tomography using [18F]2-fluoro-2-deoxy-D-glucose (FDG), blood flow was measured by the H2(15)O method. Myocardial glucose utilization was measured in regions with normal perfusion and wall motion as assessed by radionuclide ventriculography. Whole-body glucose uptake was 37+/-4 micromol x min(-1) x kg(-1) in controls and 14+/-2 mciromol x min(-1) x kg(-1) in patients (P = 0.001). Myocardial blood flow (1.09+/-0.06 vs. 0.97+/-0.04 ml x min(-1) x g(-1), controls vs. patients) and skeletal muscle (arm) blood flow (0.046+/-0.012 vs. 0.043+/-0.006 ml x min(-1) x g(-1)) were similar in the two groups (P = NS for both). In contrast, in patients both myocardial (0.38+/-0.03 vs. 0.70+/-0.03 micromol x min(-1) x g(-1), P = 0.0005) and muscle glucose uptake (0.026+/-0.004 vs. 0.056+/-0.006 micromol x min(-1) x g(-1), P = 0.005) were markedly reduced in comparison with controls. In the whole dataset, a direct relationship existed between insulin-stimulated glucose uptake in heart and skeletal muscle. Patients with a history of myocardial infarction and a low ejection fraction are insulin resistant. This insulin resistance affects both the myocardium and skeletal muscle and is independent of blood flow.Keywords
This publication has 53 references indexed in Scilit:
- Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity.Journal of Clinical Investigation, 1993
- Nuclear CardiologyNew England Journal of Medicine, 1993
- Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.Circulation, 1993
- Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 1993
- Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1991
- Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography.Circulation, 1991
- Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1990
- Temporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucoseAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990
- SIMPLE NONINVASIVE QUANTIFICATION METHOD FOR MEASURING MYOCARDIAL GLUCOSE-UTILIZATION IN HUMANS EMPLOYING POSITRON EMISSION TOMOGRAPHY AND F-18 DEOXYGLUCOSE1989
- Hormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysisMetabolism, 1988